125 related articles for article (PubMed ID: 7893444)
1. Long-term changes in psychological symptomatology associated with HIV serostatus among male injecting drug users.
Davis RF; Metzger DS; Meyers K; McLellan AT; Mulvaney FD; Navaline HA; Woody GE
AIDS; 1995 Jan; 9(1):73-9. PubMed ID: 7893444
[TBL] [Abstract][Full Text] [Related]
2. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City.
Siddiqui NS; Brown LS; Phillips RY; Vargas O; Makuch RW
AIDS; 1992 Dec; 6(12):1529-33. PubMed ID: 1492936
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.
Schlumberger MG; Desenclos JC; Papaevangelou G; Richardson SC; Ancelle-Park R
Eur J Epidemiol; 1999 Mar; 15(3):207-15. PubMed ID: 10395049
[TBL] [Abstract][Full Text] [Related]
4. Suicide probability and psychological morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV-seronegative injecting drug users.
Grassi L; Mondardini D; Pavanati M; Sighinolfi L; Serra A; Ghinelli F
J Affect Disord; 2001 May; 64(2-3):195-202. PubMed ID: 11313086
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.
Desenclos JC; Papaevangelou G; Ancelle-Park R
AIDS; 1993 Oct; 7(10):1371-7. PubMed ID: 8267911
[TBL] [Abstract][Full Text] [Related]
6. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA
Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730
[TBL] [Abstract][Full Text] [Related]
7. Death from suicide and overdose among drug injectors after disclosure of first HIV test result.
van Haastrecht HJ; Mientjes GH; van den Hoek AJ; Coutinho RA
AIDS; 1994 Dec; 8(12):1721-5. PubMed ID: 7888122
[TBL] [Abstract][Full Text] [Related]
8. Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years.
Rabkin JG; Johnson J; Lin SH; Lipsitz JD; Remien RH; Williams JB; Gorman JM
AIDS; 1997 Mar; 11(4):507-15. PubMed ID: 9084799
[TBL] [Abstract][Full Text] [Related]
9. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users.
Latkin CA; Vlahov D
Addiction; 1998 Aug; 93(8):1191-7. PubMed ID: 9813900
[TBL] [Abstract][Full Text] [Related]
10. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.
Carballo-Diéguez A; Sahs J; Goetz R; el Sadr W; Sorell S; Gorman J
Am J Drug Alcohol Abuse; 1994 Aug; 20(3):317-29. PubMed ID: 7977217
[TBL] [Abstract][Full Text] [Related]
11. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
[TBL] [Abstract][Full Text] [Related]
12. Psychological difficulties related to human immunodeficiency virus-1 infection in intravenous drug users.
Hestad K; Aukrust P; Ellertsen B; Kløve H
Acta Psychiatr Scand; 1994 Jul; 90(1):25-31. PubMed ID: 7976445
[TBL] [Abstract][Full Text] [Related]
13. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users.
Zaccarelli M; Gattari P; Rezza G; Conti S; Spizzichino L; Vlahov D; Ippolito G; Lelli V; Valenzi C
AIDS; 1994 Mar; 8(3):345-50. PubMed ID: 8031512
[TBL] [Abstract][Full Text] [Related]
14. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs.
Friedman SR; Jose B; Neaigus A; Goldstein M; Curtis R; Ildefonso G; Mota P; Des Jarlais DC
AIDS; 1994 Mar; 8(3):357-61. PubMed ID: 8031514
[TBL] [Abstract][Full Text] [Related]
15. Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users.
Waldrop-Valverde D; Ownby RL; Kumar M
Psychiatry Clin Neurosci; 2005 Aug; 59(4):372-8. PubMed ID: 16048441
[TBL] [Abstract][Full Text] [Related]
16. The impact on behavior of notifying methadone patients of their HIV serostatus.
Katz SM; Galanter M; Lifshutz H; Maslansky R
Am J Drug Alcohol Abuse; 1995 Feb; 21(1):37-45. PubMed ID: 7762543
[TBL] [Abstract][Full Text] [Related]
17. Severity of psychiatric symptoms after HIV testing.
Perry S; Jacobsberg L; Card CA; Ashman T; Frances A; Fishman B
Am J Psychiatry; 1993 May; 150(5):775-9. PubMed ID: 8480825
[TBL] [Abstract][Full Text] [Related]
18. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status.
Ironson G; LaPerriere A; Antoni M; O'Hearn P; Schneiderman N; Klimas N; Fletcher MA
Psychosom Med; 1990; 52(3):247-70. PubMed ID: 1973303
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users.
Dolezal C; Meyer-Bahlburg HF; Liu X; Ehrhardt AA; Exner TM; Rabkin JG; Gorman JM; Marder K; Stern Y
Am J Drug Alcohol Abuse; 1999 May; 25(2):281-303. PubMed ID: 10395161
[TBL] [Abstract][Full Text] [Related]
20. The psychosocial impact of HIV infection in gay men, drug users and heterosexuals. Controlled investigation.
Gala C; Pergami A; Catalan J; Durbano F; Musicco M; Riccio M; Baldeweg T; Invernizzi G
Br J Psychiatry; 1993 Nov; 163():651-9. PubMed ID: 8298835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
